Iron enhances generation of fibrin fibers in human blood: Implications for pathogenesis of stroke

Microscopy Research and Technique

Volumn 75, Issue 9, 2012, Pages 1185-1190

  Lipinski, Boguslaw ^a   Pretorius, Etheresia ^b   Oberholzer, Hester Magdalena ^b   Van Der Spuy, Wendy Jeanette ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Fibrin fibers; Hydroxyl radicals; Iron; Plasma; Stroke

Indexed keywords

BLOOD; FREE RADICALS; IRON;

BRAIN DAMAGE; FIBRIN CLOTS; FIBRIN FIBER; FREE RADICAL GENERATION; HUMAN BLOODS; HYDROXYL RADICALS; IRON IONS; PLASMINOGEN ACTIVATORS; STROKE; THROMBOLYTIC THERAPIES;

METAL IONS;

EID: 84865431617     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.22047     Document Type: Article

References (51)

1. Altamura S, Muckenthaler MU. 2009. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis 16: 879-895.
2. Alayash AI, Patel RP, Cashon RE 2001. Redox reactions of hemoglobin and myoglobin: Biological and toxicological implications. Antioxid Redox Signal 3: 313-327.
3. Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G. 2010. Heme degradation and vascular injury. Antioxid Redox Signal 12: 233-248.
4. Carbonell T, Rama R. 2007. Iron, oxidative stress and early neurological deterioration in ischemic stroke. Cur Med Chem 14: 857-874.
5. Day SM, Duquaine D, Munkada LV, Menon RG, Khan BV, Rajagopalan S, Fay WP. 2003. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107: 2601-2606.
6. Eckly A, Hechler B, Freund M, Zerr M, Cazevane JP, Lanza F, et al. 2011. Mechanism underlying FeCl(3)-induced arterial thrombosis. J Thromb Haemost 9: 779-789.
7. Franchini M, Targher G, Montagnana M, Lippi G. 2008. Iron and thrombosis. Ann Hematol 87: 167-173.
8. Ghiselli A, Laurenti O, DeMattia G, Maiani G, Ferro-Luzzi A. 1992. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Radic Biol Med 13: 621-626.
9. Hua YA, Keep RF, Hoff JT, Xi G. 2007. Brain injury after intracerebral hemorrhage. The role of thrombin and iron. Stroke 38: 759-762.
10. Inoue H, Hirobe M. 1986. Disulfide cleavage and insulin denaturation by active oxygen in copper(II)/ascorbic acid system. Chem Pharm Bull 34: 1075-1079.
11. Kamura T, Tsuda H, Yae Y, Hattori S, Ohga S, Shibata Y, Kawabata S, Hamasaki N. 1995. An abnormal fibrinogen Fukuoka II (gly-Bbeta15-->Cys) characterized by defective fibrin lateral association and mixed disulfide formation. J Biol Chem 270: 29392-29399.
12. Kato GJ, Taylor JG. 2010. Pleiotropic effects of intravascular haemolysis on vascular homeostasis. Br J Haematol 148: 690-701.
13. Kell DB. 2009. Iron behaving badly: Inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genom 2: 2.
14. Kell DB. 2010. Toward a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch Toxicol 577: 825-889.
15. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. 2008. Body iron metabolism and pathophysiology of iron overload. Int J Hematol 88: 7-15.
16. Kretz CA, Vaezzadeh N, Gross PL. 2010. Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol 30: 900-908.
17. Kruszewski M. 2004. The role of labile iron pool in the cardiovascular disease. Acta Biochemichal Polonica 51: 471-480.
18. Latallo ZS, Budzynski AZ, Lipinski B, Kowalski E. 1964. Inhibition of thrombin and of fibrin polymerization: two activities derived from plasmin-digested fibrinogen. Nature 203: 1184-1185.
19. Levy DE, Del Zoppo GJ, Demaerschalk BM, Demchuk AM, Diener HC, Howard G, Kaste M, Pancioli AM, Ringelstein EB, Spatareanu C, Wasiewski WW. 2009. Ancrod in acute ischemic stroke. Results of 500 subjects beginning treatment within 6 hours of stroke onset in the Ancrod Stroke Program. Stroke 40: 3796-3803.
20. Leys D, Deplanque D. 2006. Thrombolysis beyond the three-hour time window. Clin Exp Hypertens 28: 313-316.
21. Lipinski B. 1993. Effect of thiol-induced disulfide exchange in proteins on plasma clotting and fibrinolysis. Thromb Haemost 69: 1260.
22. Lipinski B. 2010. Modification of fibrin structure as a possible cause of thrombolytic resistance. J Thromb Thrombolysis 29: 296-298.
23. Lipinski B. 2011. Hydroxyl radical and its scavengers in health and disease. Oxid Med Cell Longev DOI:10.1155/2011/8099696.
24. Lipinski B, Egyud LG. 1992. Thiol-induced crosslinking of human blood proteins. Implications for tumor immunity. Bioorg Med Chem Lett 2: 919-924.
25. Lipinski B, Nowak A, Gurewich V. 1974. Fibrinolysis versus fibrinogenolysis of man: Resistance of fibrinogen to breakdown by fibrinolytic activity induced by venous occlusion. Experientia 30: 84-86.
26. Millerot-Serrurot E, Bertrand N, Mossiat C, Faure P, Prigent-Tessier A, Garnier P, Bejot Y, Giroud M, Beley A, Marie C. 2008. Temporal change in free iron levels after brain ischemia. Relevance to the timing of iron chelation therapy in stroke. Neurochem Int 52: 1442-1448.
27. Munro JM, Contran RS. 1988. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 58: 249-261.
28. Perron NR, Brumaghim JL. 2009. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 53: 75-100.
29. Perron NR, Wang HC, Deguire SN, Jenkins M, Lawson M, Brumaghim JL. 2010. Kinetics of iron oxidation upon polyphenol binding. Dalton Trans 39: 9982-9987.
30. Pretorius E. 2011a. Quantifying changes in fibrin fiber network morphology. Ultrastruct Pathol (in press).
31. Pretorius E. 2011b. Traditional coating techniques in scanning electron microscopy compared to uncoated charge compensator technology: Looking at human blood fibrin networks with the ZEISS ULTRA plus FEG-SEM. Microsc Res Tech 74: 343-346.
32. Pretorius E, Bronkhorst P, Briedenhann S, Smit E, Franz RC. 2009. Comparisons of the fibrin networks during pregnancy, non-pregnancy and pregnancy during dysfibrinogenaemia using the scanning electron microscope. Blood Coagul Fibrinolysis 20: 12-16.
33. Pretorius E, Oberholzer HM, van der Spuy WJ, Meiring JH. 2010a. The changed ultrastructure of fibrin networks during use of oral contraception and hormone replacement. J Thromb Thrombolysis 30: 502-506.
34. Pretorius E, Oberholzer HM, van der Spuy WJ, Meiring JH. 2010b. Age-related changes in fibrin networks and platelets of individuals over 75: A scanning electron microscopy study showing "thrombotic preparedness." J Thromb Thrombolysis 29: 271-275.
35. Pretorius E, Swanepoel AC, Oberholzer HM, van der Spuy WJ, Duim W, Wessels PF. 2011. A descriptive investigation of the ultrastructure of fibrin networks in thromboembolic ischemic stroke. J Thromb Thrombolysis 31: 507-513.
36. Puppo A, Halliwell B. 1988. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is hemoglobin a biological Fenton reagent? Biochem J 249: 185-190.
37. Robinson SR, Dang TN, Dringen R, Bishop GM. 2009. Hemin toxicity: A preventable source of brain damage following hemorrhagic stroke. Redox Rep 14: 228-235.
38. Rother RP, Bell L, Hillmen P, Gladwin MT. 2006. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293: 1653-1662.
39. Stief TW. 1991. Non-radical excited oxygen species induce selective thrombolysis in vivo. Thromb Res 62: 147-163.
40. Stief TW, Kurz J, Doss MO, Fareed J. 2000. Singlet oxygen inactivates fibrinogen, Factor V, VIII, X, and platelet aggregation in human blood. Thromb Res 97: 473-480.
41. Thomas C, Mackey MM, Diaz AA, Cox DP. 2009. Hydroxyl radical is produced via the Fenton reaction in sub-mitochondrial particles under oxidative stress: Implications for diseases associated with iron accumulation. Redox Rep 14: 102-108.
42. Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, Ibayashi S, Lida M. 2004. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J Neurol Sci 221: 11-17.
43. Undas A, Szuldrzynski K, Stepien E, Zalewski J, Godlewski J, Tracz W, Pasowicz M, Zmudka K. 2008. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress. Athertosclerosis 196: 551-557.
44. Undas A, Podolec P, Zawilska K, Pieculewicz M, Jedlinski I, Stepien E, Konarska-Kuszewska E, Weglarz P, Duszynska M, Hanschke E, Przewlocki T, Tracz W. 2009. Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke. Stroke 40: 1499-1501.
45. Van Dyke BR, Saltzman P. 1996. Hemoglobin: A mechanism of the generation of hydroxyl radicals. Free Radic Biol Med 20: 985-989.
46. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF. 2003. Heme and iron metabolism: Role in cerebral hemorrhage. J Cereb Blood Flow Metab 23: 629-652.
47. Wang X, Xu L. 2005. An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb Res 115: 95-100.
48. Weisel JW, Litvinov RI. 2008. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate. Cardiovasc Hematol Agents Med Chem 6: 161-180.
49. Woollar KJ, Sturgeon S, Chin-Dusting JP, Salem HH, Jackson S.P. 2009. Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury. J Biol Chem 284: 13110-13118.
50. Yamamoto T, Yuki S, Watanabe T, Mitsuoka M, Saito K, Kogure K. 1997. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 762: 240-242.
51. Yang X, Chasteen SD. 1999. Ferroxidase activity of ferritin: Effects of pH, buffer and Fe(II) and Fe(III) concentrations on Fe(II) autoxidation and ferroxidation. Biochem J 338: 615-618.